These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24358268)

  • 1. CD4 cell levels during treatment for tuberculosis (TB) in Ethiopian adults and clinical markers associated with CD4 lymphocytopenia.
    Skogmar S; Schön T; Balcha TT; Jemal ZH; Tibesso G; Björk J; Björkman P
    PLoS One; 2013; 8(12):e83270. PubMed ID: 24358268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a clinical scoring system for assessment of immunosuppression in patients with tuberculosis and HIV infection without access to CD4 cell testing--results from a cross-sectional study in Ethiopia.
    Skogmar S; Balcha TT; Jemal ZH; Björk J; Deressa W; Schön T; Björkman P
    Glob Health Action; 2014; 7():23105. PubMed ID: 24560255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Levels of Neopterin and C-Reactive Protein (CRP) in Tuberculosis (TB) with and without HIV Coinfection in Relation to CD4 Cell Count.
    Skogmar S; Schön T; Balcha TT; Sturegård E; Jansson M; Björkman P
    PLoS One; 2015; 10(12):e0144292. PubMed ID: 26630153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T lymphocyte subpopulations and intestinal helminthes profile among tuberculosis patients co-infected with HIV before and after anti tubercular treatment at University of Gondar Hospital, Northwest Ethiopia.
    Wondmagegn T; Damtie D; Genetu M; Biadgo B; Lemma M; Negash M
    BMC Infect Dis; 2020 Feb; 20(1):109. PubMed ID: 32033581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of tuberculosis treatment in HIV-positive adults diagnosed through active versus passive case-finding.
    Balcha TT; Skogmar S; Sturegård E; Björkman P; Winqvist N
    Glob Health Action; 2015; 8():27048. PubMed ID: 25819037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of antiretroviral and tuberculosis therapies on CD4
    Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D
    Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
    Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
    PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of etiotropic therapy on the immune status of patients with HIV infection and tuberculosis].
    Zimina VN; Kravchenko AV
    Ter Arkh; 2015; 87(11):37-41. PubMed ID: 26821414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.
    Mahan CS; Walusimbi M; Johnson DF; Lancioni C; Charlebois E; Baseke J; Chervenak KA; Mugerwa RD; Havlir DV; Mayanja-Kizza H; Whalen CC; Boom WH;
    PLoS One; 2010 Feb; 5(2):e9138. PubMed ID: 20179751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, India.
    Madan C; Chopra KK; Satyanarayana S; Surie D; Chadha V; Sachdeva KS; Khanna A; Deshmukh R; Dutta L; Namdeo A; Shukla A; Sagili K; Chauhan LS
    PLoS One; 2018; 13(10):e0204982. PubMed ID: 30281679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tuberculosis on the kinetics of CD4(+) T cell count among HIV-infected patients who initiated antiretroviral therapy early after tuberculosis treatment.
    Ku NS; Oh JO; Shin SY; Kim SB; Kim HW; Jeong SJ; Han SH; Song YG; Kim JM; Choi JY
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):226-30. PubMed ID: 22881387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 lymphocyte dynamics in Tanzanian pulmonary tuberculosis patients with and without HIV co-infection.
    Andersen AB; Range NS; Changalucha J; Praygod G; Kidola J; Faurholt-Jepsen D; Krarup H; Grewal HM; Friis H
    BMC Infect Dis; 2012 Mar; 12():66. PubMed ID: 22436147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis infection in HIV-infected Indian patients.
    Vajpayee M; Kanswal S; Seth P; Wig N; Pandey RM
    AIDS Patient Care STDS; 2004 Apr; 18(4):209-13. PubMed ID: 15142351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basis for treatment of tuberculosis among HIV-infected patients in Tanzania: the role of chest x-ray and sputum culture.
    Bakari M; Arbeit RD; Mtei L; Lyimo J; Waddell R; Matee M; Cole BF; Tvaroha S; Horsburgh CR; Soini H; Pallangyo K; von Reyn CF
    BMC Infect Dis; 2008 Mar; 8():32. PubMed ID: 18325120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
    Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
    AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection.
    Gopalakrishnan V; Bose E; Nair U; Cheng Y; Ghebremichael M
    BMC Infect Dis; 2020 Oct; 20(1):756. PubMed ID: 33059622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration and task shifting for TB/HIV care and treatment in highly resource-scarce settings: one size may not fit all.
    Van Rie A; Patel MR; Nana M; Vanden Driessche K; Tabala M; Yotebieng M; Behets F
    J Acquir Immune Defic Syndr; 2014 Mar; 65(3):e110-7. PubMed ID: 24091692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
    Shoko C; Chikobvu D; Bessong PO
    S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.
    Nakiyingi L; Ssengooba W; Nakanjako D; Armstrong D; Holshouser M; Kirenga BJ; Shah M; Mayanja-Kizza H; Joloba ML; Ellner JJ; Dorman SE; Manabe YC
    BMC Infect Dis; 2015 Feb; 15():62. PubMed ID: 25888317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire.
    Mukadi Y; Perriëns JH; St Louis ME; Brown C; Prignot J; Willame JC; Pouthier F; Kaboto M; Ryder RW; Portaels F
    Lancet; 1993 Jul; 342(8864):143-6. PubMed ID: 8101257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.